| name | endo-vitd-no-testing-pregnancy |
| description | Recommends against routine 25(OH)D testing during pregnancy. Triggers include: "Should I order a vitamin D level for this pregnant patient?" and "Is vitamin D testing indicated for asymptomatic pregnant patients?" |
Against routine vitamin D testing during pregnancy
STEP 1 — Gather Information
Confirm pregnancy status and assess for symptoms or conditions indicating vitamin D deficiency (e.g., hypocalcemia, seizures, cardiomyopathy, malabsorption, renal/hepatic disease, medications affecting vitamin D). Collect gestational age, dietary/supplement intake, and risk factors; if asymptomatic and no established indications, proceed to next step.
STEP 2 — Rule In / Rule Out
Rule out established indications for 25(OH)D testing: presence of hypocalcemia, symptomatic vitamin D deficiency, malabsorption syndromes, chronic kidney/liver disease, or use of anticonvulsants/glucocorticoids. If any indication is present, testing may be warranted; otherwise, rule out need for routine testing.
STEP 3 — Classify or Stratify
Classify the patient as pregnant without established indications for vitamin D testing (i.e., asymptomatic for deficiency and no comorbid conditions that alter vitamin D physiology).
STEP 4 — Decide
Do not order routine 25(OH)D testing; consider empiric vitamin D supplementation via prenatal vitamin or fortified foods as per guideline Recommendation 8, and reassure the patient that testing is unnecessary in this context.
Clinical Guardrails / Mimics / Pitfalls
Do not test solely for screening in asymptomatic pregnant patients; do not delay supplementation awaiting test results; avoid using testing to guide vitamin D dosing in pregnancy without symptoms; recognize that testing may be appropriate if symptoms of deficiency (e.g., hypocalcemic seizures, cardiomyopathy) arise; note that dark complexion or obesity alone do not indicate testing without clinical signs.
Concrete Clinical Example
A 28‑year‑old woman at 16 weeks gestation presents for routine prenatal care, reports no bone pain, muscle weakness, or seizures, and takes a prenatal vitamin containing 400 IU vitamin D daily. She asks whether she should have her vitamin D level checked. According to the guideline, routine testing is not indicated; she is reassured that empiric supplementation via her prenatal vitamin is appropriate and testing is unnecessary unless symptoms develop.
Source: Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290
